Cargando…
Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1
We generated two IgG1-like bispecific antibodies (BsAbs) with different molecular formats, symmetrical DVD-Ig and asymmetrical knob-in-hole (KIH), targeting the same antigens, EGFR and PD-L1 (designated as anti-EGFR/PD-L1). We performed the physiochemical and biological characterization of these two...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325241/ https://www.ncbi.nlm.nih.gov/pubmed/35890277 http://dx.doi.org/10.3390/pharmaceutics14071381 |
_version_ | 1784757001589358592 |
---|---|
author | Mohan, Nishant Agrawal, Atul Shen, Yi Winarski, Katie L. Endo, Yukinori Dokmanovic, Milos Schmiel, Deborah Zheng, Jiwen Rotstein, David S. Pelosof, Lorraine C. Wu, Wen Jin |
author_facet | Mohan, Nishant Agrawal, Atul Shen, Yi Winarski, Katie L. Endo, Yukinori Dokmanovic, Milos Schmiel, Deborah Zheng, Jiwen Rotstein, David S. Pelosof, Lorraine C. Wu, Wen Jin |
author_sort | Mohan, Nishant |
collection | PubMed |
description | We generated two IgG1-like bispecific antibodies (BsAbs) with different molecular formats, symmetrical DVD-Ig and asymmetrical knob-in-hole (KIH), targeting the same antigens, EGFR and PD-L1 (designated as anti-EGFR/PD-L1). We performed the physiochemical and biological characterization of these two formats of anti-EGFR/PD-L1 BsAbs and compared some key quality attributes and biological activities of these two formats of BsAbs. Physiochemical binding characterization data demonstrated that both formats bound EGFR and PD-L1. However, the binding affinity of the KIH format was weaker than the DVD-Ig format in Biacore binding assays. In contrast, both DVD-Ig and KIH BsAbs had similar ELISA and cell surface binding activities, comparable to mAbs. Triple-negative breast cancer (TNBC) cells and a xenograft model were used to test the potency of BsAbs and other biological activities. Results showed that anti-EGFR/PD-L1 BsAbs exhibited in vitro and in vivo antitumor proliferation activity, but there was a difference in the potencies of the respective BsAb formats (DVD-Ig and KIH) when different cells or assays were used. This study provides evidence that the potency of the BsAbs targeting the same antigens can be affected by the respective molecular features, and selection of appropriate cell lines and assays is critically important for the assay development and potency testing of BsAbs. |
format | Online Article Text |
id | pubmed-9325241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93252412022-07-27 Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 Mohan, Nishant Agrawal, Atul Shen, Yi Winarski, Katie L. Endo, Yukinori Dokmanovic, Milos Schmiel, Deborah Zheng, Jiwen Rotstein, David S. Pelosof, Lorraine C. Wu, Wen Jin Pharmaceutics Article We generated two IgG1-like bispecific antibodies (BsAbs) with different molecular formats, symmetrical DVD-Ig and asymmetrical knob-in-hole (KIH), targeting the same antigens, EGFR and PD-L1 (designated as anti-EGFR/PD-L1). We performed the physiochemical and biological characterization of these two formats of anti-EGFR/PD-L1 BsAbs and compared some key quality attributes and biological activities of these two formats of BsAbs. Physiochemical binding characterization data demonstrated that both formats bound EGFR and PD-L1. However, the binding affinity of the KIH format was weaker than the DVD-Ig format in Biacore binding assays. In contrast, both DVD-Ig and KIH BsAbs had similar ELISA and cell surface binding activities, comparable to mAbs. Triple-negative breast cancer (TNBC) cells and a xenograft model were used to test the potency of BsAbs and other biological activities. Results showed that anti-EGFR/PD-L1 BsAbs exhibited in vitro and in vivo antitumor proliferation activity, but there was a difference in the potencies of the respective BsAb formats (DVD-Ig and KIH) when different cells or assays were used. This study provides evidence that the potency of the BsAbs targeting the same antigens can be affected by the respective molecular features, and selection of appropriate cell lines and assays is critically important for the assay development and potency testing of BsAbs. MDPI 2022-06-29 /pmc/articles/PMC9325241/ /pubmed/35890277 http://dx.doi.org/10.3390/pharmaceutics14071381 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mohan, Nishant Agrawal, Atul Shen, Yi Winarski, Katie L. Endo, Yukinori Dokmanovic, Milos Schmiel, Deborah Zheng, Jiwen Rotstein, David S. Pelosof, Lorraine C. Wu, Wen Jin Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 |
title | Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 |
title_full | Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 |
title_fullStr | Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 |
title_full_unstemmed | Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 |
title_short | Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1 |
title_sort | comparative characterization of different molecular formats of bispecific antibodies targeting egfr and pd-l1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325241/ https://www.ncbi.nlm.nih.gov/pubmed/35890277 http://dx.doi.org/10.3390/pharmaceutics14071381 |
work_keys_str_mv | AT mohannishant comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT agrawalatul comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT shenyi comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT winarskikatiel comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT endoyukinori comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT dokmanovicmilos comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT schmieldeborah comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT zhengjiwen comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT rotsteindavids comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT pelosoflorrainec comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 AT wuwenjin comparativecharacterizationofdifferentmolecularformatsofbispecificantibodiestargetingegfrandpdl1 |